baicalin has been researched along with scutellarein in 5 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 1 (20.00) | 29.6817 |
2010's | 1 (20.00) | 24.3611 |
2020's | 3 (60.00) | 2.80 |
Authors | Studies |
---|---|
Cao, Y; Chen, K; Gu, J; Huang, X; Ji, R; Jiang, H; Liu, T; Luo, X; Pei, G; Wong, BL; Wong, JT; Xue, H | 1 |
Ahn, S; Jung, H; Jung, Y; Lee, YH; Lim, Y; Shin, SY; Yong, Y | 1 |
Fernandes, E; Fernandes, PA; Freitas, M; Oliveira, A; Proença, C; Ramos, MJ; Ribeiro, D; Silva, AMS; Sousa, JLC | 1 |
Chen, J; Gao, K; Huang, F; Tepe, JJ; Wang, R; Wei, GW | 1 |
Dranchak, PK; Huang, R; Inglese, J; Lamy, L; Oliphant, E; Queme, B; Tao, D; Wang, Y; Xia, M | 1 |
5 other study(ies) available for baicalin and scutellarein
Article | Year |
---|---|
3D-QSAR model of flavonoids binding at benzodiazepine site in GABAA receptors.
Topics: Benzodiazepines; Binding Sites; Calorimetry; Flavonoids; Ligands; Models, Molecular; Molecular Conformation; Mutagenesis, Site-Directed; Protein Structure, Secondary; Protein Subunits; Quantitative Structure-Activity Relationship; Receptors, GABA-A; Recombinant Proteins; Static Electricity | 2001 |
Plant-derived flavones as inhibitors of aurora B kinase and their quantitative structure-activity relationships.
Topics: Apoptosis; Aurora Kinase A; Aurora Kinase B; Aurora Kinase C; Binding Sites; Chromones; Eriocaulaceae; Flavones; G2 Phase Cell Cycle Checkpoints; HCT116 Cells; Humans; M Phase Cell Cycle Checkpoints; Microscopy, Fluorescence; Molecular Docking Simulation; Phosphorylation; Protein Kinase Inhibitors; Protein Structure, Tertiary; Quantitative Structure-Activity Relationship | 2015 |
Structural Specificity of Flavonoids in the Inhibition of Human Fructose 1,6-Bisphosphatase.
Topics: Drug Design; Enzyme Inhibitors; Flavonoids; Fructose; Fructose-Bisphosphatase; Humans; Hypoglycemic Agents; Liver; Molecular Structure | 2020 |
Perspectives on SARS-CoV-2 Main Protease Inhibitors.
Topics: Antiviral Agents; Coronavirus 3C Proteases; Humans; Protease Inhibitors | 2021 |
In vivo quantitative high-throughput screening for drug discovery and comparative toxicology.
Topics: Animals; Caenorhabditis elegans; Drug Discovery; High-Throughput Screening Assays; Humans; Proteomics; Small Molecule Libraries | 2023 |